Frailty and Polypharmacy in Primary Care
Authors:
- 26 May 2023
- journal article
- research article
- Published by SAGE Publications in Biological Research For Nursing
- Vol. 25 (4) , 658-663
Abstract
Introduction: The Clinical Frailty Scale (CFS) is a clinical judgement-based frailty tool developed from the Canadian Study of Health and Aging. Many studies on the measurement of frailty and its effect on clinical outcomes have been conducted on patients hospitalized, especially in intensive care units. The purpose of this study is to examine the relationship between polypharmacy and frailty on outpatient older adult patients in primary care. Materials and Method: This cross-sectional study included 298 patients who were aged ≥65 years and admitted to Yenimahalle Family Health Center between May-2022 and July-2022. Frailty was evaluated by using CFS. Polypharmacy was defined as five medications or more and “excessive polypharmacy” as 10 medications or more. The medications below five are grouped as “no polypharmacy”. Results: There was a statistically significance between age groups, gender, smoking status, marital status, polypharmacy status, and FS ( p = .003 and η 2 : .20; p < .001 and Cohen d: .80; p = .018 and Cohen d: .35; p < .001 and Cohen d: 1.10 and p < .001 and η 2 : 1.45 respectively). A strong, positive correlation was found between polypharmacy and the frailty score. Conclusion: Polypharmacy, especially excessive polypharmacy, may be a promising adjunct to frailty in identifying older patients whose health is more likely to worsen. Providers in primary care should also consider frailty when prescribing drugs.Keywords
This publication has 22 references indexed in Scilit:
- An evaluation of medication appropriateness and frailty among residents of aged care homes in MalaysiaMedicine, 2017
- Singapore Healthy Older People Everyday (HOPE) Study: Prevalence of Frailty and Associated Factors in Older AdultsJournal of the American Medical Directors Association, 2017
- Frailty, Kidney Function, and Polypharmacy: The Atherosclerosis Risk in Communities (ARIC) StudyAmerican Journal of Kidney Diseases, 2017
- Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort StudyJournal of the American Geriatrics Society, 2016
- Adverse Outcomes in Relation to Polypharmacy in Robust and Frail Older Hospital PatientsJournal of the American Medical Directors Association, 2016
- The Korean version of the FRAIL scale: clinical feasibility and validity of assessing the frailty status of Korean elderlyThe Korean Journal of Internal Medicine, 2016
- Frailty Screening in the Community Using the FRAIL ScaleJournal of the American Medical Directors Association, 2015
- Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old peoplePharmacoepidemiology and Drug Safety, 2015
- Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in SwedenBMJ Open, 2013
- Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomesJournal of Clinical Epidemiology, 2012